BCLS ACQUISITION CORP's ticker is BLSA and the CUSIP is G0904B105. A total of 46 filers reported holding BCLS ACQUISITION CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,138,000 | +4.1% | 213,377 | +2.8% | 0.10% | -29.9% |
| Q2 2022 | $2,054,000 | +0.9% | 207,477 | +0.6% | 0.14% | -34.2% |
| Q1 2022 | $2,036,000 | +0.7% | 206,257 | 0.0% | 0.22% | -38.1% |
| Q4 2021 | $2,021,000 | +6.1% | 206,257 | +7.8% | 0.35% | +22.5% |
| Q3 2021 | $1,905,000 | -5.4% | 191,272 | 0.0% | 0.29% | -3.7% |
| Q2 2021 | $2,014,000 | -0.4% | 191,272 | 0.0% | 0.30% | -24.1% |
| Q1 2021 | $2,022,000 | -1.7% | 191,272 | +3.6% | 0.40% | -31.7% |
| Q4 2020 | $2,056,000 | – | 184,600 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 843,122 | $8,347,000 | 4.65% |
| Logan Stone Capital, LLC | 175,698 | $1,739,000 | 1.28% |
| Samsara BioCapital, LLC | 300,000 | $2,970,000 | 0.79% |
| Bain Capital Life Sciences Investors, LLC | 487,500 | $4,826,000 | 0.57% |
| COMMODORE CAPITAL LP | 250,000 | $2,475,000 | 0.52% |
| Altium Capital Management LP | 100,000 | $990,000 | 0.40% |
| Exos Asset Management LLC | 70,367 | $697,000 | 0.36% |
| RA Capital Management | 1,250,000 | $12,375,000 | 0.33% |
| Boxer Capital, LLC | 500,000 | $4,950,000 | 0.31% |
| PFM Health Sciences, LP | 464,103 | $4,595,000 | 0.18% |